Grants per year
Personal profile
Certifications and Licenses
| Internal Medicine | |
| Infectious Disease |
Training Experience
| 1996 | Residency, Berkshire Medical Center |
| 2006 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
MBBS, University of Ibadan, Nigeria
… → 1991
Research interests
- Fever of Unknown Origin
- Fungal Infections
- Human Immunodeficiency Virus (HIV/AIDS)
- Influenza
- Lyme Disease
- Malaria
- Musculoskeletal Infections
- Osteomyelitis
- Prosthetic Joint Infections
- Sexually Transmitted Diseases
- Skin Infections (MRSA)
- Soft
Fingerprint Dive into the research topics where Babafemi O Taiwo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
HIV
Medicine & Life Sciences
HIV-1
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Tenofovir
Medicine & Life Sciences
HIV Infections
Medicine & Life Sciences
Nigeria
Medicine & Life Sciences
Viral Load
Medicine & Life Sciences
Lamivudine
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2004 2023
Protocol Funds, Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636]
University of California, Los Angeles, National Institute of Allergy and Infectious Diseases
12/1/18 → 11/30/19
Project: Research project
Financial Management
Acquired Immunodeficiency Syndrome
Clinical Trials
Budgets
Clinical Protocols
ACTG A5322 Protocol Vice Chair Support
University of California, Los Angeles, National Institute of Allergy and Infectious Diseases
12/1/18 → 11/30/19
Project: Research project
Publications
Clinical Core - The Center for Innovation in Point-of-Care Technologies for HIV/AIDS at Northwestern University (C-THAN)
Achenbach, C. J., D'Aquila, R. T., Hawkins, C. A., Hirschhorn, L. R., Maiga, M., Murphy, R. L., Taiwo, B. O. & Hou, L.
National Institute of Biomedical Imaging and Bioengineering
9/11/18 → 5/31/23
Project: Research project
Point-of-Care Systems
Acquired Immunodeficiency Syndrome
HIV
Biomedical Engineering
Mali
Subproject for SP0047319: iCare Supplement
Birkett, M. A., Janulis, P. F., Lorenzo Redondo, R., Phillips ii, G. L. & Taiwo, B. O.
National Institute of Child Health and Human Development
9/6/18 → 8/31/20
Project: Research project
HIV
Nigeria
Research
Capacity Building
Telemedicine
Intensive Combination Approach to Rollback the Epidemic (iCARE) in Nigerian Adolescents
Hirschhorn, L. R., Janulis, P. F. & Taiwo, B. O.
National Institute of Child Health and Human Development
9/6/18 → 8/31/20
Project: Research project
HIV
Nigeria
Research
Capacity Building
Telemedicine
Research Output 2000 2019
2
Citations
(Scopus)
Comparable viral decay with initial dolutegravir plus lamivudine versus dolutegravir-based triple therapy
Gillman, J., Janulis, P. F., Gulick, R., Wallis, C. L., Berzins, B., Bedimo, R., Smith, K., Aboud, M. & Taiwo, B. O., Aug 1 2019, In : The Journal of antimicrobial chemotherapy. 74, 8, p. 2365-2369 5 p.Research output: Contribution to journal › Article
Lamivudine
Viral Load
Therapeutics
Nonparametric Statistics
dolutegravir
1
Citation
(Scopus)
Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons
Riestenberg, R. A., Furman, A., Cowen, A., Pawlowksi, A., Schneider, D., Lewis, A. A., Kelly, S., Taiwo, B., Achenbach, C., Palella, F., Stone, N. J., Lloyd-Jones, D. M. & Feinstein, M. J., Mar 2019, In : American heart journal. 209, p. 79-87 9 p.Research output: Contribution to journal › Article
Hydroxymethylglutaryl-CoA Reductase Inhibitors
HIV
Lipids
HIV Infections
Cardiovascular Diseases
5
Citations
(Scopus)
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: Week 48 outcomes from ACTG 5353
Nyaku, A. N., Zheng, L., Gulick, R. M., Olefsky, M., Berzins, B., Wallis, C. L., Godfrey, C., Sax, P. E., Acosta, E. P., Haas, D. W., Smith, K. Y., Sha, B. E., Van Dam, C. N., Taiwo, B. O., Hawkins, E., Kumwenda, J., Hernandez, A., Ha, B., Jarocki, B., Tegha, G. & 1 others, , Jan 1 2019, In : Journal of Antimicrobial Chemotherapy. 74, 5, p. 1376-1380 5 p.Research output: Contribution to journal › Article
Lamivudine
HIV-1
RNA
Safety
dolutegravir
7
Citations
(Scopus)
Frailty, neurocognitive impairment, or both in predicting poor health outcomes among adults living with human immunodeficiency virus
Erlandson, K. M., Perez, J., Abdo, M., Robertson, K., Ellis, R. J., Koletar, S. L., Kalayjian, R., Taiwo, B., Palella, F. J. & Tassiopoulos, K., Jan 1 2019, In : Clinical Infectious Diseases. 68, 1, p. 131-138 8 p.Research output: Contribution to journal › Article
HIV
Health
Activities of Daily Living
CD4 Lymphocyte Count
Observational Studies
Initial Antiretroviral Therapy in an Integrase Inhibitor Era: Can We Do Better?
Kelly, S. G., Masters, M. C. & Taiwo, B. O., Sep 2019, In : Infectious disease clinics of North America. 33, 3, p. 681-692 12 p.Research output: Contribution to journal › Review article
Integrase Inhibitors
Drug Therapy
Reverse Transcriptase Inhibitors
Lamivudine
Virus Diseases